- Home
- CLPR vs TELA Comparison
CLPR vs TELA Comparison
Compare CLPR & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPR
- TELA
- Stock Information
- Founded
- CLPR 2015
- TELA 2012
- Country
- CLPR United States
- TELA United States
- Employees
- CLPR N/A
- TELA N/A
- Industry
- CLPR Real Estate Investment Trusts
- TELA Medical/Dental Instruments
- Sector
- CLPR Real Estate
- TELA Health Care
- Exchange
- CLPR Nasdaq
- TELA Nasdaq
- Market Cap
- CLPR 67.0M
- TELA 60.6M
- IPO Year
- CLPR 2017
- TELA 2019
- Fundamental
- Price
- CLPR $3.94
- TELA $1.44
- Analyst Decision
- CLPR
- TELA Buy
- Analyst Count
- CLPR 0
- TELA 3
- Target Price
- CLPR N/A
- TELA $5.33
- AVG Volume (30 Days)
- CLPR 59.3K
- TELA 70.3K
- Earning Date
- CLPR 11-06-2025
- TELA 11-06-2025
- Dividend Yield
- CLPR 9.64%
- TELA N/A
- EPS Growth
- CLPR N/A
- TELA N/A
- EPS
- CLPR N/A
- TELA N/A
- Revenue
- CLPR $154,103,000.00
- TELA $75,323,000.00
- Revenue This Year
- CLPR N/A
- TELA $25.72
- Revenue Next Year
- CLPR N/A
- TELA $22.03
- P/E Ratio
- CLPR N/A
- TELA N/A
- Revenue Growth
- CLPR 7.69
- TELA 16.34
- 52 Week Low
- CLPR $3.39
- TELA $0.86
- 52 Week High
- CLPR $6.83
- TELA $3.26
- Technical
- Relative Strength Index (RSI)
- CLPR 44.31
- TELA 37.40
- Support Level
- CLPR $3.93
- TELA $1.42
- Resistance Level
- CLPR $4.24
- TELA $1.51
- Average True Range (ATR)
- CLPR 0.17
- TELA 0.06
- MACD
- CLPR -0.01
- TELA -0.00
- Stochastic Oscillator
- CLPR 29.64
- TELA 14.29
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.